NDC 66435-102

RIBASPHERE

Ribavirin

RIBASPHERE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Kadmon Pharmaceuticals, Llc. The primary component is Ribavirin.

Product ID66435-102_dffc1bdc-d81c-457e-ace7-ee5c6032f7b0
NDC66435-102
Product TypeHuman Prescription Drug
Proprietary NameRIBASPHERE
Generic NameRibavirin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2005-12-05
Marketing CategoryANDA / ANDA
Application NumberANDA077456
Labeler NameKadmon Pharmaceuticals, LLC
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 66435-102-16

168 TABLET, FILM COATED in 1 BOTTLE (66435-102-16)
Marketing Start Date2005-12-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66435-102-95 [66435010295]

RIBASPHERE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077456
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-12-05
Marketing End Date2010-06-29

NDC 66435-102-16 [66435010216]

RIBASPHERE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA077456
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-12-05
Marketing End Date2019-09-30

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:12f3dec1-4299-4b93-8013-6fa6a963fd81
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 616133
  • 616131
  • 896790
  • 902313
  • 902312
  • 248109
  • 616129
  • 1863148
  • 1298334
  • 757599
  • 597718
  • 754738
  • 597722
  • 757597

    • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    Medicade Reported Pricing

    66435010216 RIBASPHERE 200 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "RIBASPHERE" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    66435-102RIBASPHERERIBASPHERE
    66435-104RIBASPHERERIBASPHERE
    66435-101RibasphereRibasphere
    66435-103RIBASPHERERIBASPHERE
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    0187-0007VirazoleRibavirin

    Trademark Results [RIBASPHERE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RIBASPHERE
    RIBASPHERE
    76535804 2952736 Live/Registered
    KADMON CORPORATION, LLC
    2003-07-29
    RIBASPHERE
    RIBASPHERE
    76412404 2887092 Live/Registered
    KADMON CORPORATION, LLC
    2002-05-24
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.